Published in Eur Heart J on January 01, 1983
Chronic beta 1-adrenoceptor antagonist treatment sensitizes beta 2-adrenoceptors, but desensitizes M2-muscarinic receptors in the human right atrium. Br J Pharmacol (1990) 0.93
The rise of cardiovascular medicine. Eur Heart J (2012) 0.92
The role of beta-blockers in the treatment of cardiomyopathy and ischaemic heart failure. Drugs (1994) 0.77
Longitudinal myocardial contraction improves early during titration with metoprolol CR/XL in patients with heart failure. Heart (2002) 0.76
Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial. Lancet (1981) 4.75
Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group. Lancet (1993) 3.20
Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J (1975) 2.71
Long-term beta-blockade in dilated cardiomyopathy. Effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol. Circulation (1989) 2.24
A novel polymorphism in the gene coding for the beta(1)-adrenergic receptor associated with survival in patients with heart failure. Eur Heart J (2000) 1.96
Beneficial effects of long-term beta-blockade in congestive cardiomyopathy. Br Heart J (1980) 1.85
Beta-blockers and sudden cardiac death. Ann Intern Med (1995) 1.83
Exercise hemodynamics and myocardial metabolism during long-term beta-adrenergic blockade in severe heart failure. J Am Coll Cardiol (1991) 1.66
The appropriateness of performing coronary angiography and coronary artery revascularization in a Swedish population. JAMA (1994) 1.64
Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of antibodies against the beta 1-adrenoceptor with positive chronotropic effect. Circulation (1994) 1.63
Prolongation of survival in congestive cardiomyopathy by beta-receptor blockade. Lancet (1979) 1.55
Metoprolol-induced reduction in postinfarction mortality: pooled results from five double-blind randomized trials. Eur Heart J (1992) 1.55
Metabolism and excretion of nitric oxide in humans. An experimental and clinical study. Circ Res (1993) 1.53
Effects of sympathetic vasoconstrictor fibres, noradrenaline and vasopressin on the intestinal vascular resistance during constant blood flow or blood pressure. Acta Physiol Scand (1966) 1.52
Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy. J Clin Invest (1993) 1.51
Myocardial turnover of endogenous opioids and calcitonin-gene-related peptide in the human heart and the effects of spinal cord stimulation on pacing-induced angina pectoris. Cardiology (1998) 1.51
Female sex is associated with increased mortality and morbidity early, but not late, after coronary artery bypass grafting. Eur Heart J (1996) 1.51
Early changes in longitudinal performance predict future improvement in global left ventricular function during long term beta adrenergic blockade. Heart (2000) 1.49
Heart rate dependency of cardiac performance in heart failure patients treated with metoprolol. Eur Heart J (1999) 1.48
Prognosis of acute myocardial infarction in diabetic and non-diabetic patients. Diabet Med (1993) 1.47
Eligibility for intravenous thrombolysis in suspected acute myocardial infarction. Circulation (1990) 1.46
Effects of spinal cord stimulation in angina pectoris induced by pacing and possible mechanisms of action. BMJ (1993) 1.44
Mapping of a functional autoimmune epitope on the beta 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy. J Clin Invest (1990) 1.44
Potential risk of beta-blockade withdrawal in congestive heart failure due to abrupt autonomic changes. Int J Cardiol (1999) 1.40
Phenformin and pulmonary hypertension. Br Heart J (1973) 1.40
A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation. J Intern Med (2003) 1.39
Hypertonic saline without or with dextran-70 in the treatment of experimental acute myocardial ischemia and reperfusion. Crit Care Med (1999) 1.37
The effects of transcutaneous electrical nerve stimulation in patients with severe angina pectoris. Circulation (1985) 1.34
Distress correlates with the degree of chest pain: a description of patients awaiting revascularisation. Heart (1996) 1.30
Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension. J Hypertens (2000) 1.26
Functional autoimmune epitope on alpha 1-adrenergic receptors in patients with malignant hypertension. Lancet (1994) 1.21
Apex cardiogram and systolic time intervals in acute myocardial infarction and effects of practolol. Br Heart J (1974) 1.20
Ventricular dimensions and wall motion assessed by echocardiography in patients with arrhythmogenic right ventricular dysplasia. Eur Heart J (1988) 1.18
In vivo MR imaging of magnetically labeled human embryonic stem cells. Life Sci (2006) 1.15
Changes in early and late diastolic filling patterns induced by long-term adrenergic beta-blockade in patients with idiopathic dilated cardiomyopathy. Circulation (1996) 1.14
Effect of acupuncture in patients with angina pectoris. Eur Heart J (1991) 1.14
Early prediction of acute myocardial infarction from clinical history, examination and electrocardiogram in the emergency room. Am J Cardiol (1991) 1.12
Patients admitted to the emergency room with symptoms indicative of acute myocardial infarction. J Intern Med (1991) 1.12
Glucose turnover and adipose tissue lipolysis are insulin-resistant in healthy relatives of type 2 diabetes patients: is cellular insulin resistance a secondary phenomenon? Diabetes (1999) 1.11
Are patients truthful about their smoking habits? A validation of self-report about smoking cessation with biochemical markers of smoking activity amongst patients with ischaemic heart disease. J Intern Med (2001) 1.11
Effect of smoking reduction and cessation on cardiovascular risk factors. Nicotine Tob Res (2001) 1.10
Adverse effects of beta-blockade withdrawal in patients with congestive cardiomyopathy. Br Heart J (1980) 1.10
Antigenic analysis of the second extra-cellular loop of the human beta-adrenergic receptors. Clin Exp Immunol (1989) 1.07
Haemodynamic effects of a new beta 1-receptor agonist in acute myocardial infarction. A useful antidote to unwanted cardiac effects of beta-blocking agents. Br Heart J (1979) 1.07
A double-blind trial of metoprolol in acute myocardial infarction. Effects on ventricular tachyarrhythmias. N Engl J Med (1983) 1.06
Short- and long-term clinical outcome after Q wave and non-Q wave myocardial infarction in a large patient population. Circulation (1989) 1.05
In vitro work load and rat heart metabolism. I. Effect on protein synthesis. Acta Physiol Scand (1972) 1.05
The role of beta-blockers in left ventricular dysfunction and heart failure. Drugs (1997) 1.04
Quality of life five years after myocardial infarction. Eur Heart J (1989) 1.04
Complications prior to revascularization among patients waiting for coronary artery bypass grafting and percutaneous transluminal coronary angioplasty. Eur Heart J (1996) 1.04
Spectrum and outcome of congestive heart failure in a hospitalized population. Am Heart J (1993) 1.04
Peptides derived from cardiovascular G-protein-coupled receptors induce morphological cardiomyopathic changes in immunized rabbits. J Mol Cell Cardiol (1997) 1.00
The epidemiology of a coronary waiting list. A description of all of the patients. J Intern Med (1994) 1.00
Age and sex differences in cardiovascular reactivity to adrenergic agonists, mental stress and isometric exercise in normal subjects. Scand J Clin Lab Invest (1988) 1.00
Improved exercise hemodynamic status in dilated cardiomyopathy after beta-adrenergic blockade treatment. J Am Coll Cardiol (1994) 0.99
Challenges of subgroup analyses in multinational clinical trials: experiences from the MERIT-HF trial. Am Heart J (2001) 0.99
Effects of thoracic epidural anesthesia on coronary arteries and arterioles in patients with coronary artery disease. Anesthesiology (1990) 0.99
High prevalence of antibodies against beta 1- and beta 2-adrenoceptors in patients with primary electrical cardiac abnormalities. J Am Coll Cardiol (1995) 0.98
Different responses to dobutamine in the presence of carvedilol or metoprolol in patients with chronic heart failure. Heart (2003) 0.98
The Göteborg metoprolol trial. Effects on mortality and morbidity in acute myocardial infarction. Circulation (1983) 0.98
Induction of cardiomyopathy in severe combined immunodeficiency mice by transfer of lymphocytes from patients with idiopathic dilated cardiomyopathy. Autoimmunity (2000) 0.97
Catecholamine metabolism during pacing-induced angina pectoris and the effect of transcutaneous electrical nerve stimulation. Am Heart J (1987) 0.96
Mortality and morbidity during a five-year follow-up of diabetics with myocardial infarction. Acta Med Scand (1988) 0.95
Autoantibodies against cardiac G-protein-coupled receptors define different populations with cardiomyopathies but not with hypertension. Clin Immunol Immunopathol (1994) 0.95
Effects of obesity and weight loss on left ventricular mass and relative wall thickness: survey and intervention study. BMJ (1997) 0.94
An echocardiographic evaluation of patients with idiopathic heart failure. Chest (1995) 0.93
Bioenergetic, functional and morphological consequences of postinfarct cardiac remodeling in the rat. J Mol Cell Cardiol (1999) 0.93
Distortion of non-invasive cardiac pulse curves. A capillary-damped pick-up and a calibration unit forapex cardiograms and other pulse curves. Br Heart J (1977) 0.93
Treatment of pain in acute myocardial infarction. Br Heart J (1989) 0.93
Mechanical versus biological valve prosthesis: a ten-year comparison regarding function and quality of life. Ann Thorac Surg (1995) 0.92
Left ventricular wall stress and systolic function in untreated primary hypertension. Hypertension (1985) 0.92
Failure to demonstrate enterovirus aetiology in Swedish patients with dilated cardiomyopathy. J Med Virol (1993) 0.92
A placebo-controlled study of growth hormone in patients with congestive heart failure. Eur Heart J (1998) 0.91
Probing the immunological properties of the extracellular domains of the human beta(1)-adrenoceptor. J Autoimmun (1999) 0.91